Haemek Medical Center
Afula, Israel
NCT Number: NCT03626844
Comparison of maternal outcomes following manual lysis of placenta 15 vs 30 minutes after delivery. A primary outcome of the drop in hemoglobin will be compared between the two groups. Secondary outcomes include blood transfusion rate, maternal satisfaction, time to first breastfeeding, length of hospital stay, infection rate etc.
Trial opening soon.
Get Notified18 year–45 year
Female
Interventional
Not applicable
Afula, Israel
Women undergoing spontaneous vaginal delivery at term with epidural analgesia will be randomly assigned to one of two groups: (1) manual removal of the placenta 15 minutes after delivery or (2) expectant management for 30 minutes, followed by manual removal of the placenta if it has not been delivered.
Both groups will receive active management of the third stage of labor, including oxytocin administration. Participants who develop active bleeding will undergo immediate manual removal of the placenta according to standard clinical care. Manual removal will be performed under epidural analgesia, and prophylactic antibiotics will be administered.
The primary outcome will be the difference in postpartum hemoglobin reduction between the two groups. Secondary outcomes will include incidence of blood transfusion, maternal satisfaction, time to first breastfeeding, length of hospital stay, infection rate.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Manual Lysis of Placenta after 15 minutes: We administer prophylactic antibiotics, under epidural analgesia, under aseptic conditions, we perform manual lysis of placenta by introducing the hand through the vagina to the uterine cavity, separating and removing the placenta.
Other names: Manual Lysis of Placenta after 15 minutes
Manual Lysis of Placenta after 30 minutes: We administer prophylactic antibiotics, under epidural analgesia, under aseptic conditions, we perform manual lysis of placenta by introducing the hand through the vagina to the uterine cavity, separating and removing the placenta.
Other names: Manual Lysis of Placenta after 30 minutes
Time frame: within 24 hours after delivery
The difference between Hemoglobin levels before and after delivery
Time frame: 7 days
Number and type of blood products given peripartum
Time frame: 7 days
Calculation of estimated blood loss during delivery by accepted formulas
Time frame: within one week of delivery
Rate of developing fever after delivery
Time frame: 7 days
Time until first breastfeeding
Time frame: 7 days
Length of Hospital stay in days
Time frame: 7 days
Level of maternal satisfaction from the delivery process and interventions as evaluated by a numerical scale from 1 to 5 with 5 being highly satisfied
Time frame: up to 6 weeks postpartum
The difference between Hemoglobin levels before and after delivery
Contact information is provided by the study sponsor or research team.
Mais Abu Nofal, M.D.
CONTACT
Raed Salim, M.D.
CONTACT
Holy Family Hospital, Nazareth, Israel
Other
Maternal Outcomes Following Manual Lysis of the Placenta After Fifteen Compared to Thirty Minutes. A Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07688512
Dystocia, Elective Cesarean Section
View Trial DetailsNCT07688122
Female Urogenital Diseases and Pregnancy Complications, Gamification in Health Education
View Trial DetailsNCT07636421
Blood Loss, Surgical, Cesarean Section
Buraidah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT07626502
Delayed and Secondary Postpartum Hemorrhage, Female Urogenital Diseases and Pregnancy Complications
View Trial Details